Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11351
PUT
Telesat
TSAT
$771M
| $94.6K | ﹤0.01% |
11,000
-5,600
| -34% | -$52.9K |
|
11352
Acumen Pharmaceuticals
ABOS
$193M
| $94.6K | ﹤0.01% |
23,351
-107,765
| -82% | -$406K |
|
|
NVX
11353
NOVONIX
NVX
$110M
| $94.5K | ﹤0.01% |
+41,278
| New | +$83.3K |
|
11354
Redwire
RDW
$3.39B
| $94.5K | ﹤0.01% |
21,532
+10,250
| +91% | +$32.6K |
|
|
ETW
11355
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $94.2K | ﹤0.01% |
11,482
-3,491
| -23% | -$27.7K |
|
11356
CALL
First Advantage
FA
$3.71B
| $94.1K | ﹤0.01% |
+5,800
| New | +$94.6K |
|
11357
PUT
Olema Pharmaceuticals
OLMA
$930M
| $94K | ﹤0.01% |
8,300
-18,800
| -69% | -$243K |
|
11358
PUT
Aldeyra Therapeutics
ALDX
$94.1M
| $93.8K | ﹤0.01% |
28,700
-37,500
| -57% | -$123K |
|
11359
PUT
i3 Verticals
IIIV
$294M
| $93.8K | ﹤0.01% |
4,100
-300
| -7% | -$6.23K |
|
|
PVL
11360
CALL
Permianville Royalty Trust
PVL
$58.1M
| $93.8K | ﹤0.01% |
69,000
+41,100
| +147% | +$61.3K |
|
11361
PUT
New Mountain Finance
NMFC
$730M
| $93.8K | ﹤0.01% |
7,400
+300
| +4% | +$3.82K |
|
11362
CALL
Coherus Oncology
CHRS
$185M
| $93.7K | ﹤0.01% |
39,200
-20,100
| -34% | -$49.5K |
|
11363
PUT
ALX Oncology
ALXO
$271M
| $93.7K | ﹤0.01% |
8,400
-1,900
| -18% | -$26.7K |
|
11364
Trinity Capital Inc
TRIN
$1.72B
| $93.5K | ﹤0.01% |
6,369
-189,161
| -97% | -$2.73M |
|
11365
CALL
Veru
VERU
$46.5M
| $93.4K | ﹤0.01% |
13,340
-20,600
| -61% | -$110K |
|
11366
PUT
OFS Capital
OFS
$48.1M
| $93.3K | ﹤0.01% |
9,400
+1,700
| +22% | +$18.8K |
|
11367
Urban One Class D
UONEK
$23.4M
| $93.3K | ﹤0.01% |
+4,573
| New | +$140K |
|
|
AGTI
11368
DELISTED
Agiliti Inc
AGTI
| $93.2K | ﹤0.01% |
9,208
-115,842
| -93% | -$970K |
|
11369
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $93.1K | ﹤0.01% |
4,096
-28,953
| -88% | -$611K |
|
11370
PUT
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.3B
| $93.1K | ﹤0.01% |
5,200
-17,800
| -77% | -$316K |
|
11371
PUT
GraniteShares 2x Short NVDA Daily ETF
NVD
$48.6M
| $93.1K | ﹤0.01% |
+736
| New | +$187K |
|
11372
PUT
Honda
HMC
$41B
| $93.1K | ﹤0.01% |
2,500
-13,200
| -84% | -$454K |
|
11373
Custom Truck One Source
CTOS
$2.4B
| $92.9K | ﹤0.01% |
15,958
-115,345
| -88% | -$716K |
|
|
RSVR
11374
PUT
Reservoir Media
RSVR
$657M
| $92.8K | ﹤0.01% |
+11,700
| New | +$83.2K |
|
|
MRSN
11375
CALL
DELISTED
Mersana Therapeutics
MRSN
| $92.7K | ﹤0.01% |
828
-868
| -51% | -$86.3K |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.